Novartis AG (NVSEF)
134.75
-3.02
(-2.19%)
USD |
OTCM |
Sep 14, 16:00
Novartis Market Cap : 246.67B for Sept. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 14, 2026 | 246.67B |
| September 11, 2026 | 252.19B |
| September 10, 2026 | 252.52B |
| September 09, 2026 | 253.53B |
| September 08, 2026 | 300.67B |
| September 04, 2026 | 300.67B |
| September 03, 2026 | 300.67B |
| September 02, 2026 | 287.02B |
| September 01, 2026 | 296.72B |
| August 31, 2026 | 265.45B |
| August 28, 2026 | 299.48B |
| August 27, 2026 | 299.48B |
| August 26, 2026 | 299.48B |
| August 25, 2026 | 299.48B |
| August 24, 2026 | 299.48B |
| August 21, 2026 | 288.51B |
| August 20, 2026 | 288.51B |
| August 19, 2026 | 292.89B |
| August 18, 2026 | 274.09B |
| August 17, 2026 | 267.14B |
| August 14, 2026 | 289.04B |
| August 13, 2026 | 289.04B |
| August 12, 2026 | 289.04B |
| August 11, 2026 | 289.04B |
| August 10, 2026 | 277.18B |
| Date | Value |
|---|---|
| August 07, 2026 | 278.10B |
| August 06, 2026 | 278.10B |
| August 05, 2026 | 278.10B |
| August 04, 2026 | 278.10B |
| August 03, 2026 | 278.10B |
| July 31, 2026 | 290.18B |
| July 30, 2026 | 290.18B |
| July 29, 2026 | 290.18B |
| July 28, 2026 | 274.58B |
| July 27, 2026 | 274.58B |
| July 24, 2026 | 282.76B |
| July 23, 2026 | 282.76B |
| July 22, 2026 | 280.09B |
| July 21, 2026 | 280.07B |
| July 20, 2026 | 280.07B |
| July 17, 2026 | 278.05B |
| July 16, 2026 | 278.05B |
| July 15, 2026 | 267.52B |
| July 14, 2026 | 272.35B |
| July 13, 2026 | 281.26B |
| July 10, 2026 | 281.26B |
| July 09, 2026 | 292.89B |
| July 08, 2026 | 292.89B |
| July 07, 2026 | 292.89B |
| July 06, 2026 | 289.66B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Roche Holding AG | 302.53B |
| Addex Therapeutics Ltd. | 3.241M |
| Oculis Holding AG | 621.64M |
| Sandoz Group AG | 35.19B |
| Galderma Group AG | 44.32B |
Market Cap Related Metrics
| PE Ratio | 20.34 |
| PS Ratio | 4.736 |
| Price to Book Value | 5.938 |
| Price to Free Cash Flow | 17.09 |
| Price | 134.75 |
| Earnings Yield | 4.92% |
| Operating PE Ratio | 16.01 |
| Normalized PE Ratio | 18.95 |